AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulte-Altedorneburg, G.
Right arrow Articles by Mayer, T.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulte-Altedorneburg, G.
Right arrow Articles by Mayer, T.E.

INTERVENTIONAL

Ischemic and Hemorrhagic Complications after Intra-Arterial Fibrinolysis in Vertebrobasilar Occlusion

G. Schulte-Altedorneburga, H. Brückmanna, G.F. Hamannb,e, M. Mullc, M. Liebetraub,e, W. Weberd, D. Kühned and T.E. Mayera

a Department of Neuroradiology, University of Munich, Klinikum Grosshadern, Germany
b Department of Neurology, University of Munich, Klinikum Grosshadern, Germany
c Department of Neuroradiology, University of Aachen, Germany
d Department of Neuroradiology, Alfried-Krupp Hospital Essen, Germany
e Department of Neurology, Dr. Horst Schmidt Klinik GmbH, Wiesbaden, Germany

Address correspondence to Gernot Schulte-Altedorneburg MD, Clinic of Diagnostic and Interventional Neuroradiology, University of Saarland, Klinikum Homburg/Saar, D-66421 Homburg/Saar, Germany; e-mail: gernot.sad{at}gmx.de

BACKGROUND AND PURPOSE: To evaluate the incidence and location of hemorrhagic and ischemic lesions after local intra-arterial (IA) fibrinolysis in patients with acute vertebrobasilar occlusion (VBO).

METHODS: One hundred forty-three patients with VBO treated with local IA fibrinolysis were retrospectively evaluated. Two different thrombolytic substances, namely urokinase (UK, n = 57 patients) and recombinant tissue plasminogen activator (rtPA, n = 86 patients), were used. Incidence and location of intracranial hemorrhage and ischemic infarction were assessed by means of 403 peri-interventional CT and MR imaging scans. Recanalization success and bleeding rate were correlated with the type and dosage of fibrinolytic agent. Multiple logistic regression was used for statistical analysis.

RESULTS: Intracranial hemorrhage was detected in 46 (32%) patients. Bleeding rate was significantly higher for high-dose rtPA than for UK (36% versus 21%, P < .01). Neurologic outcome was worse in patients with postinterventional bleeding (P < .001). Ischemic infarctions were present in 136 (95%) patients. Ischemic lesions of the occipital lobe and thalamus were more frequently seen in the case of successful recanalization than after absent recanalization (P < .005). Occlusion of the postcommunicating segment of the posterior cerebral artery after successful recanalization was seen in 39% of patients.

CONCLUSIONS: In acute VBO, bleeding rate after IA rtPA seems to be higher than that using IA UK, especially after high-dose rtPA. Ischemic lesion patterns after successful local IA fibrinolysis are common and correspond to the frequent distal migration of the thrombus. Novel recanalization techniques allowing for endovascular thrombectomy are needed to reduce ischemic and hemorrhagic complications in the treatment of acute VBO.




This article has been cited by other articles:


Home page
StrokeHome page
C. Brekenfeld, G. Schroth, M. El-Koussy, K. Nedeltchev, M. Reinert, J. Slotboom, and J. Gralla
Mechanical Thromboembolectomy for Acute Ischemic Stroke: Comparison of the Catch Thromboectomy Device and the Merci Retriever In Vivo
Stroke, April 1, 2008; 39(4): 1213 - 1219.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Ogawa, E. Mori, K. Minematsu, W. Taki, A. Takahashi, S. Nemoto, S. Miyamoto, M. Sasaki, T. Inoue, and for The MELT Japan Study Group
Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan
Stroke, October 1, 2007; 38(10): 2633 - 2639.
[Abstract] [Full Text] [PDF]